We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | NYSE:MRK | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.88 | -0.68% | 127.92 | 129.76 | 127.985 | 129.76 | 7,446,078 | 01:00:00 |
From May 2022 to May 2024
By Colin Kellaher
Merck & Co. on Thursday said it agreed to buy Vence, a provider of virtual-fencing technology for rotational grazing and livestock management, in a deal that bolsters the drugmaker's animal-health portfolio,
Financial terms of the deal, which the Kenilworth, N.J., company expects to complete by the end of the month, weren't disclosed.
Merck said Vence provides enhanced technology for producers and ranchers to track, monitor and manage the movement of cattle through a platform of virtual fencing solutions. The technology is currently available in the U.S. and parts of Australia.
Merck's animal-health segment accounted for more than 10% of the company's second-quarter sales of nearly $14.6 billion.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 22, 2022 07:58 ET (11:58 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Merck Chart |
1 Month Merck Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
